WOCKHARDT
|
The Current P/B Ratio of WOCKHARDT is 5.16.
| Share Price | ₹1,377.4 | Jan 20,2026 |
| Market Cap | ₹22,382.8 Cr | |
| Book Value | ₹4,341.0 Cr | Mar2025 - Consolidated Results |
| Price/Book | 5.16x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of WOCKHARDT
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹22,382.8 Cr] as on Jan 20,2026
(/) Book Value [ ₹4,341.0 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 5.16x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '5.16 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WOCKHARDT !
The chart below summarizes the trend in P/B Ratio of WOCKHARDT over the last five years.
Historical PB (Price/Book ) ratio chart of WOCKHARDT
PB Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.20x.
- WOCKHARDT 's operated at median p/b ratio of 1.36x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/b ratio peaked in Mar2025 at 5.31x.
- WOCKHARDT 's p/b ratio hit its five-year low in Mar2023 of 0.66x.
How does WOCKHARDT 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| WOCKHARDT | 4,341.00 | 5.16 | 22,382.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.36 | 386,773.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 10.65 | 159,357.0 |
| CIPLA LTD | 31,079.30 | 3.56 | 110,628.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 17.72 | 134,529.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 2.89 | 96,441.5 |
| MANKIND PHARMA LTD | 14,288.70 | 6.07 | 86,682.9 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.67 | 87,839.2 |
| LUPIN LTD | 17,119.50 | 5.71 | 97,727.5 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.00 | 65,145.6 |
| ABBOTT INDIA LTD | 4,204.27 | 13.95 | 58,658.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WOCKHARDT 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.00x |
| Max industry PB | 17.72x |
| Median industry PB | 5.36x |
| Average industry PB | 6.97x |
You may also like the below Video Courses